Greater Boston: Hard Problems, Big Ideas Download as image Share on X
Startups, scaleups and selected public or acquired companies with local product-building teams. Greater Boston, including Cambridge, Somerville and Devens. Curated by Cosign and listed alphabetically.
Biological mineral recovery and contaminant treatment.
Pilot tests enriched nickel using biology, pointing toward a different way to recover valuable minerals.
Cosign Agile robots built for our world, taking on tough work in factories and warehouses.
Atlas is a product now, with Hyundai and DeepMind work planned to test whether humanoids can earn their factory space.
Cosign Cell therapies, programmed faster for more people.
Mapping three hundred cell states expands the possibilities for programming cells to restore functions disease takes away.
Cosign At PathAI, we’re dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories
Labcorp is taking its digital pathology platform nationwide—moving slide review into software that connects labs, specialists and AI.
Cosign CAD for biology, built to design better medicines faster.
Just delivered a high-yield cell line for a complex cancer antibody—tackling the manufacturing bottleneck that follows a promising drug design.
Cosign Automated stem cell manufacturing for personalized regenerative medicine.
New tissue-manufacturing results tackle a hard limit on cell therapies: making the same living product reliably, again and again.
Cosign A therapeutics company at the intersection of biology, machine learning, and biological engineering.
Its severe-asthma drug is in two Phase 3 trials, testing whether patients can control inflammation with treatment just twice a year.
Cosign Business travel, expenses and events connected in one platform for travelers and finance teams.
Combining travel and spending takes aim at the admin around every business trip, connecting what employees book with what finance sees.
Cosign The AI-ready scientific record for experiments, data, and discovery.
Lilly’s drug-discovery models are now inside Benchling, giving smaller biotechs access to predictions built on decades of pharmaceutical research.
Cosign Compact fusion plants built around powerful magnets, working toward abundant energy.
SPARC’s magnets are installed. Proving net-energy fusion is the next step toward abundant power without burning fossil fuels.
Cosign Build autonomous labs to accelerate biotech R&D.
After selling its biosecurity business, it’s concentrating on autonomous labs—with MIT and Caltech among the next sites for scaling robotic experimentation.
Cosign Neutral-atom quantum computers and application development.
Cloud access and a Japanese supercomputer location bring quantum hardware closer to the researchers trying to find its practical uses.
Cosign Smart dispensers that turn tap water into personalized drinks.
New menu options reach existing dispensers, changing what people drink without adding another stream of single-use bottles.
Cosign DataRobot delivers the industry-leading AI applications and platform that maximize impact and minimize risk for your business.
Now working with Chevron on autonomous inspections—using AI to assess operating conditions so robots can spend less time waiting for mission approval.
Cosign America’s top-rated virtual insurance agent for comparing, buying, and managing insurance.
Its ChatGPT experience now returns real insurance quotes in 11 states—bringing price comparison and coverage questions into the same conversation.
Cosign Electrochemical cement production without conventional kiln heating.
Its cement is already in the field. The next challenge is a commercial plant for a material normally made with intense heat.
Cosign Community health intelligence from wastewater.
Wastewater tests across 1,000 locations look for population-wide health signals before individual cases tell the full story.
Cosign Professional 3D printing from design through finished parts.
New PreForm releases improve the path from a digital design to a usable part, making fabrication more accessible.
Cosign The world's first Operating System for Science powered by Scientific Superintelligence™
Its automated lab is producing RNA and CAR-T results, testing whether AI can accelerate the discovery of new medicines.
Cosign Software and support for group care
Its first Parkland group visit tests another way to deliver care, where one clinical session can also create support between patients.
Cosign Show 5 more
Cosign
